Nothing Special   »   [go: up one dir, main page]

Ngui et al., 2000 - Google Patents

Cytochrome P450 3A4-mediated interaction of diclofenac and quinidine

Ngui et al., 2000

Document ID
12856767717537526953
Author
Ngui J
Tang W
Stearns R
Shou M
Miller R
Zhang Y
Lin J
Baillie T
Publication year
Publication venue
Drug metabolism and disposition

External Links

Snippet

The metabolism of diclofenac to its 5-hydroxylated derivative in humans is catalyzed by cytochrome P450 (CYP) 3A4. We report herein that in vitro this biotransformation pathway is stimulated by quinidine. When diclofenac was incubated with human liver microsomes in the …
Continue reading at dmd.aspetjournals.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90245—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase

Similar Documents

Publication Publication Date Title
Ngui et al. Cytochrome P450 3A4-mediated interaction of diclofenac and quinidine
Kostrubsky et al. The use of human hepatocyte cultures to study the induction of cytochrome P-450
Ngui et al. In vitro stimulation of warfarin metabolism by quinidine: increases in the formation of 4′-and 10-hydroxywarfarin
Erickson et al. Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450
Prueksaritanont et al. In vitro metabolism of simvastatin in humans [SBT] identification of metabolizing enzymes and effect of the drug on hepatic P450s
Ring et al. Identification of the human cytochromes P450 responsible for atomoxetine metabolism
Kobayashi et al. Identification of cytochrome P450 isoforms involved in citalopramN-demethylation by human liver microsomes
Wen et al. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9
Ohyama et al. A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor
McGinnity et al. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes
Shimada et al. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes
Akutsu et al. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation
Lanza et al. Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome P450 enzymes
Rahman et al. Differential regulation of glutathione by oxidants and dexamethasone in alveolar epithelial cells
Gantenbein et al. Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A
Masubuchi et al. Diclofenac-induced inactivation of CYP3A4 and its stimulation by quinidine
Attar et al. Cytochrome P450 2C8 and flavin-containing monooxygenases are involved in the metabolism of tazarotenic acid in humans
Kharasch et al. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity
Iwatsubo et al. Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes
Monostory et al. Ipriflavone as an inhibitor of human cytochrome P450 enzymes
Hutzler et al. Activation of CYP2C9-mediated metabolism by a series of dapsone analogs: kinetics and structural requirements
Yao et al. Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19
Abbas et al. In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms
Goldman et al. In vitro hepatic oxidative biotransformation of trimethoprim
Luukkanen et al. Glucuronidation of 1-hydroxypyrene by human liver microsomes and human UDP-glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: development of a high-sensitivity glucuronidation assay for human tissue